JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1995; 25:1673-1680
© 1995 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pavri, B.
Right arrow Articles by William, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pavri, B.
Right arrow Articles by William, G

Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation

BB Pavri, SS O'Nunain, JB Newell, JN Ruskin, and G William

Cardiac Unit, Massachusetts General Hospital, Boston 02114, USA.

OBJECTIVES. We studied the duration and prognostic significance of atrial arrhythmias in the denervated transplanted heart, specifically the occurrence of atrial fibrillation in the absence of vagal modulation. BACKGROUND. Substantial animal data indicate that vagally induced dispersion of atrial refractoriness plays a central role in the induction and maintenance of atrial fibrillation. METHODS. We studied the occurrence of atrial arrhythmias in the denervated hearts of 88 consecutive orthotopic transplantations in 85 patients by means of continuous telemetry and all available electrocardiographic tracings. RESULTS. Fifty percent of recipients (44 of 88) developed at least one atrial arrhythmia. Atrial fibrillation occurred 23 times (21 recipients), atrial flutter 39 times (26 recipients), ectopic atrial tachycardia 3 times (3 recipients) and supraventricular tachycardia 18 times (11 recipients). The number of atrial fibrillation and atrial flutter episodes did not differ (23 vs. 39, p = 0.072), but the mean duration of atrial flutter was longer than that of atrial fibrillation (37.0 +/- 10 vs. 6.6 +/- 3.6 h, p = 0.014). Atrial fibrillation was associated with an increased risk of subsequent death (10 of 21 recipients with vs. 15 of 67 without atrial fibrillation, risk ratio 3.15 +/- 0.18, p = 0.005 by Cox proportional hazards model). All 5 recipients who developed "late" atrial fibrillation (> 2 weeks after transplantation) died versus 5 of 16 who developed atrial fibrillation within the first 2 weeks (p = 0.007). Causes of death included rejection (three recipients), allograft failure (two recipients), infection (three recipients) and multiorgan failure (two recipients). Atrial fibrillation was not associated with age, gender, ischemic time, reason for transplantation, echocardiographic variables, invasive hemodynamic variables or biopsy grade. Mean time from atrial arrhythmia to echocardiography was 2.7 +/- 3.3 days; that to biopsy was 4.8 +/- 6.3 days. Atrial flutter was not associated with subsequent death. Only 7 (15.9%) of 44 recipients demonstrated moderate or severe allograft rejection at the time of the arrhythmia. CONCLUSIONS. Atrial arrhythmias occur frequently in the denervated transplanted heart, often in the absence of significant rejection. Late atrial fibrillation may be associated with an increased all-cause mortality.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
W. E. Cohn, I. D. Gregoric, B. Radovancevic, R. K. Wolf, and O.H. Frazier
Atrial Fibrillation After Cardiac Transplantation: Experience in 498 Consecutive Cases
Ann. Thorac. Surg., January 1, 2008; 85(1): 56 - 58.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Zierer, S. J. Melby, R. K. Voeller, T. J. Guthrie, A. S. Al-Dadah, B. F. Meyers, M. K. Pasque, G. A. Ewald, M. R. Moon, and N. Moazami
Significance of Neurologic Complications in the Modern Era of Cardiac Transplantation
Ann. Thorac. Surg., May 1, 2007; 83(5): 1684 - 1690.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
C. E. Come and P. A. Shapiro
Supraventricular Tachycardia Associated With Methylphenidate Treatment in a Heart Transplant Recipient
Psychosomatics, October 1, 2005; 46(5): 461 - 463.
[Full Text] [PDF]


Home page
ChestHome page
T. D. Nielsen, T. Bahnson, R. D. Davis, and S. M. Palmer
Atrial Fibrillation After Pulmonary Transplant
Chest, August 1, 2004; 126(2): 496 - 500.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. Ribbing, G. Mönnig, K. Wasmer, Gün. Breithardt, and L. Eckardt
Catheter ablation of atrial tachycardia due to recipient-to-donor transatrial conduction after orthotopic heart transplantation
Europace, January 1, 2004; 6(3): 215 - 219.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. Amar, N. Roistacher, V. W. Rusch, D. H. Y. Leung, I. Ginsburg, H. Zhang, M. S. Bains, R. J. Downey, R. J. Korst, and R. J. Ginsberg
Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 790 - 798.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Singh, P. I. Johnson, R. E. Lee, E. Orfei, V. A. Lonchyna, H. J. Sullivan, A. Montoya, H. Tran, W. H. Wehrmacher, and R. D. Wurster
TOPOGRAPHY OF CARDIAC GANGLIA IN THE ADULT HUMAN HEART
J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 943 - 953.
[Abstract] [Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1995 by the American College of Cardiology Foundation.